About: New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on October 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в жовтні 2010 (uk) 2010 ഒക്ടോബര്‍ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) مقالة علمية نشرت في أكتوبر 2010 (ar) scientific article published on October 2010 (en)
publication date	wds:Q37779102-CD2D3BCA-2A40-42B7-BAA8-7CC832ACB967
publication date	2010-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37779102-C7A8DADA-023C-49EA-973C-14FF5924047B
language of work or name	English
cites work	wds:Q37779102-02B26E22-C2DF-4E83-BC4C-98EE4399A943 wds:Q37779102-478CEBC8-166A-4748-AA7B-8A1B96386D75 wds:Q37779102-5147DFA2-3C12-4589-996A-AD44201DC98D wds:Q37779102-560866C6-6EEB-4CFF-8B7C-BEF348DD0BD9 wds:Q37779102-58B901B6-0A94-447E-9E38-3227DEA5C324 wds:Q37779102-6CB4BD0F-9B48-4180-91E7-9A207F4BD836 wds:Q37779102-77B8CDA1-5E9E-4FF7-9227-215ADF2B342C wds:Q37779102-8151EDB7-DC60-4977-8FB8-06DA333B3517 wds:Q37779102-93D0999E-ADED-4AC4-A1BC-A3862F236AA9 wds:Q37779102-9CE9579F-607F-481B-BEE1-6177436271C2 wds:Q37779102-A22BD34D-B293-4B56-8032-BE9F68B30F8E wds:Q37779102-A9F8CC5D-EBEB-4EE9-AB1E-E728ED8233AE wds:Q37779102-AD2C7B22-61AA-4A95-960A-6B05B168A594 wds:Q37779102-AF8C672F-36B2-4819-B858-CE9D774502B6 wds:Q37779102-B8598E55-57D6-4CA7-804E-800E13E24BF4 wds:Q37779102-C0CB9041-14D3-4F44-AF8A-3D001B18352D wds:Q37779102-C142D0BF-D922-47E2-94C6-16BB71476DB7 wds:Q37779102-C75904A5-0F95-42FC-981C-FF0747C44490 wds:Q37779102-CC0523A9-2832-4903-81BB-DBF202208D9C wds:Q37779102-CF7CE994-2FBB-4789-849E-A0AD1620B5F1 wds:Q37779102-D6AEAF33-B328-4C66-9B4F-B6F8F1818D71 wds:Q37779102-DC7982F9-3D75-46CB-81C4-962D1D74D574 wds:Q37779102-DFADAE3E-50C6-4A48-A4C9-70E7D4E69BE1 wds:Q37779102-E5C9CF58-0378-48D1-80E8-6EFE366E57E1 wds:Q37779102-FB0DA7CE-FBC2-431A-830D-94B2385F6026
cites work	Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species Nitazoxanide for the treatment of Clostridium difficile colitis Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide A case-control study of community-associated Clostridium difficile infection In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile In vitro activity of OPT-80 against Clostridium difficile Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004 Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni In vitro activities of OPT-80 and comparator drugs against intestinal bacteria Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections. Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses In vitro and in vivo activities of nitazoxanide against Clostridium difficile Vancomycin-resistant staphylococci and enterococci: epidemiology and control What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? Emergence of reduced susceptibility to metronidazole in Clostridium difficile. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
author name string	wds:Q37779102-9100ECC1-3256-4BF8-B5A4-190830B297AC
author name string	Alan P Johnson
rdfs:label	New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (en) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (nl) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (ast)
skos:prefLabel	New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (en) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (nl) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (ast)
name	New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (en) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (nl) New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (ast)
title	wds:Q37779102-B081DDE2-214C-4B3B-AF45-738FDE8A8B7D
title	New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile (en)
page(s)	wds:Q37779102-4B4F3F6A-908A-496A-AE45-C25041EC5050
page(s)	1389-1399
instance of	wds:Q37779102-181F1033-746C-468D-B766-B082832C7B52 wds:Q37779102-f14298ca-f76a-4fdc-9956-da77523ef9ac
instance of	review article scholarly article
main subject	wds:Q37779102-97CD9D40-6ECE-460E-A209-5C3EE0F402E6 wds:Q37779102-BF0FABB6-D78A-4222-AFD5-89044266FA5D
main subject	antibiotic Clostridium difficile
PubMed ID	wds:Q37779102-36BA1F2F-C51D-4408-B672-B7F5FA5F78E8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20698814
PubMed ID	20698814
published in	wds:Q37779102-9FAFF239-05F9-4D86-85EC-F89476B0DD76
published in	Expert Opinion on Therapeutic Patents

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software